MASSDEVICE ON CALL — Medical device makers may still have a way to go in ensuring the increased speed and efficiency they were promised when they signed off on the latest iteration of the FDA’s user fee program.
The program, which began in 2003 has returned "mixed results," according to Forbes writer John Graham, who conducted an analysis for the Pacific Research Institute of the FDA’s expanded budget and subsequent changes in productivity.
Despite increased funding, the FDA’s processes may have become less productive, Graham wrote.
Robotic surgery safe for transoral treatment of head, neck cancer
Researchers conclude that transoral robotic surgery is feasible and safe, and that the procedure may play an big role in head and neck cancer.
Read more
Israeli device maker meets endpoints in U.S. insulin pump trial
Israel’s InsuLine Medical touted positive findings for its U.S. clinical trials of the InsuPatch insulin pump.
Read more
Abbott launches OneLab data management
Amid the "big data" movement, through which researchers are looking to glean new insight by inventing creative ways to manage the wealth of data generated on a daily basis, Abbott (NYSE:ABT) launched its OneLab web-based software platform to improve productivity in the lab.
Read more
Docs decry Medicare’s wheelchair approval process
Physicians and caregivers called on the Centers for Medicare & Medicaid to fix the reimbursement process for rehabilitation patients who need wheelchairs.
Read more
